ARSB and mucolipidosis type II: Indeed, triclabendazole reduced the transduced GAG core proteins in the MPS model cells, including IDUA KO cells, ARSB KO cells, and GUSB KO cells, as well as in GNPTAB KO cells, a model cell for mucolipidosis type II.